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Abstract 
Background. Healthcare associated infections (HAIs) represent a serious problem for public health, as they 
increase the morbidity and mortality rates, present a relevant financial burden, and significantly contribute 
to the antimicrobial resistance. 
Methods. The aim of this review was to investigate the literature about HAIs, with particular reference to 
hospital environments and the role of cleaning and disinfection procedures. Hospital environments are an 
essential reservoir for HAIs cross transmission, and the application of appropriate procedures related to 
hand hygiene and disinfection/sterilization of surfaces and instruments remain key strategies for control-
ling HAIs. 
Results. Different procedures, based on the risk associated with the healthcare procedure, are recommended 
for hand hygiene: washing with soap and water, antiseptic rubbing with alcohol-based disinfectants, anti-
septic and surgical hand washing. Environmental surfaces can be treated with different products, and the 
mostly used are chlorine-based and polyphenolic disinfectant. The reprocessing of instruments is related to 
their use according to the Spaulding’s classification. In addition, scientific evidence demonstrated the great 
relevance of the “bundles” (small set of practices performed together) in controlling HAIs. 
Conclusions. Research agenda should include the improvement of well-known effective preventive procedures 
and the development of new bundles devoted to high-risk procedures and specific microorganisms.
Introduction
Healthcare associated infections (HAIs) 
remain an issue of great concern for public 
health. These infections, already known as 
“nosocomial” or “hospital”, are defined as 
infections that occur in patients during the 
process of care in a hospital or other health 
care facilities, not present or incubating 
at the time of admission. These infections 
increase the morbidity and mortality rates 
and present a not negligible financial burden; 
in addition, they significantly contribute to 
the antimicrobial resistance (1). With regards 
to their frequency World Health Organization 
(WHO) estimated that, globally, HAIs 
are the most frequent adverse outcomes 
during care delivery and no countries were 
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able to completely eliminate this problem. 
Consequently, each year, hundreds of 
millions of individuals are affected by HAIs 
worldwide (2). According to the Centers for 
Diseases Control (CDC) of Atlanta, every 
day about one in 31 hospital patients has at 
least one HAI. During the course of 2015, 
3% of hospitalized patients in United States 
had one or more HAIs for a total of 687,000 
cases; about 72,000 hospital patients with 
HAIs died during the hospitalization (3). 
Based on large studies from USA and 
Europe, HAIs incidence ranged from 130 
to 203 episodes per 1000 patient-days and 
pooled cumulative incidence was about 170 
episodes per 1000 patient-days in adult high-
risk patients in industrialized countries (4).
Regarding the current frequency of HAIs, 
in European countries the prevalence ranges 
from 7.6% to 10.3%, but this percentage is 
strongly related to influencing variables such 
as hospital’s dimension, kind of department, 
days of hospitalization and preventive 
measures. In addition, prevalence changes 
from one European country to another 
and varies over the decades (5). Indeed, 
the HAIs prevalence estimated during the 
course of the years 1995-2010 extensively 
varied in different European countries: in 
UK was about 9.0%, while in Germany was 
about 3.6%, in Italy 6.7%, in France 4.4%, 
in Spain 8.8%, in Netherlands 7.2% and 
in Switzerland 8.8% (4). Besides, a study 
performed on Greek HAIs demonstrated 
that the 10% of hospitalized patients had a 
HAI, and many infections were determined 
by antibiotic-resistant opportunistics and/
or pathogens (6). In the same period, the 
low- and middle-income countries presented 
a prevalence ranging from 5.7% to 19.1%. 
In particular, the highest prevalence was 
recovered in Albania (19.1%), followed 
by Mali (18.7), Tunisia (17.9%), Brazil 
(14%), Turkey (12.5%), Indonesia (7.1%) 
and Ghana (6.7%) (4). Furthermore, a 
study carried out in India, in a tertiary care 
hospital, reported a HAIs prevalence equal 
to 11.7% (7). However, these data cannot 
be considered as totally accurate because, 
in general, it is difficult to estimate the real 
frequency of HAIs. Furthermore, in low- 
and middle-income countries, a regular 
surveillance of HAIs is difficult to perform, 
and studies devoted to this issue are lack.
As regard to the Italian situation, there are 
some data reported by specific researches. 
A multicenter study, conducted in 2004 
by the Italian National Institute of Health 
on 50 hospitals for a total of about 6,000 
patients, reported that more than half of 
studied patients had an infection during 
the hospitalization. Southern Italy and 
Italian major islands presented the largest 
percentage of HAIs (48%), followed by 
northern and central Italy (respectively 
30% and 22%) (8). These percentages are 
higher respect to those reported by other 
studies and international data, probably 
because of different definition of the “HAI 
case”. Another Italian study, performed in 
2011 on some Sicilian hospitals, reported 
a prevalence of HAIs equal to 3.2 for 100 
patients compared to national prevalence 
equal to 6.3 for 100 patients (9).
Even if data on frequency of HAIs are 
heterogeneous, HAIs are a global problem 
and, thus, their financial burden cannot be 
neglected, both in term of direct and indirect 
costs (10). First of all, HAIs can extend the 
hospital stays’ length and increase the costs 
for healthcare assistance. In a multi-center 
study conducted in China, the average length 
of hospital stay was 21 days in patients 
with HAIs compared to 16 days on average 
for patients without HAIs, resulting in a 
hospitalization cost of about € 700 more 
for patients with HAIs respect to those not 
affected (11). Similarly, in other countries 
HAIs determines relevant annual financial 
loss: it has estimated that only direct costs 
were about € 7 billions in Europe and $ 6.5 
billions in the United States (12). Besides, 
HAIs cause also indirect costs as lost 
productivity of affected patients.
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Another important problem related 
to HAIs is their role in the occurrence of 
the antimicrobial resistance. Indeed, the 
well-known widespread use of antibiotics 
has led to the development of resistant 
microorganisms, especially in the healthcare 
setting (13). In the United States, for 
example, many hospitals reported an 
increase in infections caused by Methicillin-
Resistant Staphylococcus Aureus (MRSA) 
and Vancomycin Resistant Staphylococcus 
Aureus (VRSA) (14). Likewise, a recent study 
performed on European data demonstrated 
that 63.5% of infections with antibiotic-
resistant bacteria were associated with 
healthcare, suggesting that infections with 
antibiotic-resistant bacteria mostly occur in 
hospitals and other health-care scenarios; 
particular concern is given to the Italian 
situation, because Italy had the highest 
estimated burden of antibiotic resistant 
bacteria than other European countries (15, 
16). Besides, HAIs caused by multi-drug 
resistance micro-organisms also frequently 
occurs, making infection’s treatment more 
difficult and expensive (17).
The staff and the health environment 
represent the intermedia transmission vectors 
of infections correlated to the multidrug 
resistant care (18). For all the reasons 
reported above, appropriate prevention 
strategies are needed in order to control the 
occurrence of HAIs.
The aim of the present review was to 
investigate literature data about healthcare 
associated infections, with particular 
reference to the hospital environment 
and the role of cleaning and disinfection 
procedures.
Hospital environment as a reservoir 
for cross transmission
“Healthcare” organization consists of 
the following three fundamental elements: 
the structures or areas where patient care 
is taken, the tools, materials and devices 
used for carrying out patient care and 
safely manage the building, and people 
circulating in these environments (patients, 
staff and visitors) (19). Each of these 
elements contributes to increase the risk 
of microbiological contamination of the 
hospital environment and, thus, determines a 
potential reservoir for the cross transmission 
of HAIs.
First of all, hospital’s areas and structures 
undergo construction and renovation 
routinely and extraordinarily, such as the 
removal of an old elevator or the cleaning 
of the elevator horn, that can contaminate 
the air, the water and surfaces (20, 21). 
Besides, environmental surfaces, that are 
all the surfaces that do not come into direct 
contact with patients during care (i.e. 
x-ray machines, instrument carts or floors, 
walls, tabletops, etc.), objects and medical 
devices using for patients’ care (i.e. blood 
pressure cuffs, stethoscopes, electronic 
thermometers, infusion pumps, and 
hemodialysis machines) can be contaminated 
and, consequently, represent a potential 
vehicle of microorganisms’ transmission 
(20, 21). Patients often come into contact 
with microorganisms that can resist on the 
surfaces and in the environmental matrices 
(air, water) for a variable period of time 
(sometimes a long period of time). The 
type and quantity of these depends on the 
characteristics of the built environment, 
the circulation of personnel, patients and 
visitors, the climate conditions (in particular 
the survival of these microorganisms 
is strongly influenced by the degree of 
humidity), the presence of surfaces and 
equipment consisting of materials that 
promote microbial growth and survival, from 
the rapidity at which they are removed from 
the air and from the correct implementation 
of all the expected hygiene standards. In 
particular, it should be emphasized that 
gram-positive bacteria survive more easily 
in environments (but also on surfaces) that 
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are dry, unlike gram-negative (as well as 
fungi) that survive mainly in dirty and wet 
environments (22).
As regards to the microorganisms present 
in the hospital settings, it is well-known that 
each hospital has a particular “biological 
imprinting”; however, there are some 
bacteria more present and/or hazardous 
respect to others. Among these, Legionella 
spp. is a relevant microorganism for hospital 
environments; it is a gram-negative bacterium 
that can naturally be found in hot and/or cold 
water; consequently, water systems, wet 
ground, air conditioning systems, cooling 
towers, spas, pools and fountains are at 
higher-risk to be contaminated. Transmission 
of Legionella spp. occurs by the inhalation of 
droplets containing the bacterium. Biofilm 
accumulation promote algae and protozoa 
proliferation, providing essential nutrients 
for Legionella and interfering with the 
action of disinfectants; thus, the formation 
of biofilm is a main risk factor for Legionella 
colonization and survival. Hospital water 
distribution systems are at higher-risk 
of Legionella contamination (23, 24). 
Approximately 28.2 cases of legionellosis 
per million inhabitants were estimated in 
2016 in Italy (95% of cases were community-
acquired and 5% were HAIs) (25). Other 
relevant microorganisms potentially present 
in water lines and associated to HAIs are 
mycobacteria. Scientific literature reported 
different species of mycobacteria associated 
with nosocomial infections through water 
transmission, including Mycobacterium (M.) 
avium complex, M. fortuitum, M. gordonae, 
M. marinum, M. scrofulaceum, M. terrae, 
M. ulcerans and M. xenopi, M. chelonae, M. 
immunogenum, M. abscessus, M. kansasii, 
M. ulcerans, M. Szulgai, M. simiae, M. 
palstre. (26). These bacteria can cause an 
immuno-mediated pulmonary disease or 
a direct infection, with colonisation of the 
respiratory tract. The latter occurs mainly 
but not exclusively in patients previously 
affected by structural pulmonary diseases 
(i.e. chronic obstructive pulmonary disease), 
which can also determine the deaths of 
these patients (27). Another rapidly growing 
bacterium of the same species presents 
also in tap water, named M. porcinum, can 
cause wound infections, related to the use of 
intravascular catheter and/or osteomyelitis 
(28). Regarding this specific microorganism, 
it is important to note that, in the last years, 
mycobacteria, especially M. tuberculosis, 
become multidrug or pandrug resistants, 
determining incurable infectious diseases 
(29).
Another microorganism that causes a 
great number of HAIs is the Clostridium 
(C.) difficile, a gram-positive, spore-forming 
bacterium, transmitted by fecal-oral pathway 
both in direct and indirect mode. Antibiotic 
therapies often alter normal intestinal flora, 
causing an excessive proliferation of this 
bacterium, whose spores can survive on 
clothes, surfaces, bodies or devices of health 
workers for a long period of time (up to 
five months). Therefore, the contact with 
contaminated surfaces, devices, or hands 
increases the risk of infection (30). As an 
example, C. difficile is found in 90% of 
the bathrooms used by C. difficile positive 
individuals. The prevalence of C. difficile 
asymptomatic colonization was found about 
10 times higher in hospitalized patients (10-
25%) than in the healthy population (2-3%) 
(31). The risk increases if the previous 
occupant or a roommate is positive for 
C. difficile, or the roommate is receiving 
antibiotic therapy (32).
Another microorganism commonly 
associated to HAIs is Klebsiella (K) 
pneumoniae, a cause of pneumonia, 
bloodstream infection, wound or surgical 
site infections, and meningitis. Klebsiella 
is normally present in the human intestine 
(where it does not cause disease) and, 
therefore, is often found in human stool. 
It is unusual that healthy people get 
Klebsiella infections, while patients are at 
risk undergoing treatment with ventilators, 
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catheters intravenous or undergo long 
antibiotic treatment. It should also be 
reported that this bacterium developed 
a certain resistance to carbapenem and 
cephalosporins (33, 34). For example, in 
2016 in France, it was reported that 29% 
of detected K. pneumoniae was resistant to 
third-generation cephalosporins (35).
Another Gram-negative bacterium related 
to HAIs is Acinetobacter (A.) baumannii, 
an anaerobic coccobacillus able to colonize 
many districts of the human body such as 
intestine, throat and skin, and able to survive 
in the environment even up to one month. 
It is recognized as an important cause of 
respiratory, urinary, hematic and wound 
infections associated with a high mortality 
rate (36).
A. baumanni is often resistant to many 
antibiotics, determining a serious problem 
for the treatment of these infections. It 
seems that the most effective treatment is 
represented by polymyoxins in monotherapy 
or in combination with other agents. A 
recent meta-analysis shows that there is 
no improvement in the rates of healing 
or mortality when polytherapy is used 
respect to monotherapy, even if the rates of 
microbiological eradication result higher 
(37). 
The problems connected to the most 
appropriate choice for a therapy, considering 
the growing resistance of this bacterium, lays 
the foundations for the study of prevention 
measures to avoid or limit the spread of A. 
baumanni, paying particular attention to 
hand hygiene and environmental disinfection 
(38).
Gram-negative bacteria causing HAIs 
include also Pseudomonas (P.) aeruginosa, 
a microorganism commonly found in water 
and soil or as an opportunistic pathogen of 
humans, animals and plants. P. aeruginosa 
causes HAIs especially in subjects who are 
already immunosuppressed, particularly if 
they are ventilated or intubated or treated 
with contaminated solution, and mainly by 
burns or cystic fibrosis (39, 40). Therefore, 
its transmission is both environmental 
but also through direct contact or through 
droplets released by coughing and sneezing 
from already infected people (39). Besides, 
cases of Pseudomonas infections have 
been reported as a result of using infected 
bronchoscopes. For this reason, although 
periodic monitoring of clinical endoscopes is 
not currently prescribed as a routinely practice, 
CDC promotes the cultural surveillance of 
duodenoscopes in addition to the reprocessing 
procedures. For this reason, it is important to 
promote the microbiological surveillance of 
bronchoscopes in order to prevent nosocomial 
infections transmitted through the use of 
infected bronchoscopes (41).
An important cause of mortality in 
hospi ta l s  i s  Meth ic i l l in -Res is tan t 
Staphylococcus aureus (MRSA). Previously 
present only as infections acquired in 
health facilities, a community-associated 
variant (CA-MRSA) has also been found 
(35, 42). Indeed, bacteremia determined 
by Staphylococcus aureus causes 20-30% 
of hospital mortality. If despite targeted 
antibiotic therapy positive cultures and 
fever are still present after 72-96 hours, it is 
appropriate to suppose a complication such 
as endocarditis or septic thrombophlebitis. 
For this reason, it is necessary to monitor 
body temperature and sample blood cultures 
every 24-48 hours in order to identify the 
focus early and act towards an eradication 
(43, 44). 
Other relevant causes of HAIs are 
Enterococcus  and  Staphylococcus 
epidermidis, mycetes (in particular Candida 
and Aspergillus), the multi-resistant 
Pneumococcus, the vancomycin-resistant 
Enterococcus. Among the gram-negative 
bacteria, Escherichia coli and Proteus 
mirabilis show resistance to broad-spectrum 
of beta-lactamases. In addition, Enterobacter 
and Citrobacter freundii are resistant to third-
generation cephalosporins (5). In particular, 
enterobacteria represent one of the main 
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Adherence to hand hygiene procedures 
among personnel is very variable, ranging 
between 5% and 89% worldwide, with a 
total average of about 38% (49). Health 
workers recognize in the lack of time, in being 
overburdened by work and in the excessive 
bureaucracy an important role for not fully 
observing hand hygiene procedures. A recent 
survey, carried out in a large hospital in 
Vietnam, highlighted that the main barriers 
for the adherence to the guidelines for hand 
hygiene were the lack of adequate products 
and their improper positioning, patients 
overcrowding, work overload, skin reactions 
caused by some antiseptics, lack of risk 
perception, old habits and forgetfulness (51).
In order to overcome these barriers to 
hand hygiene among healthcare personnel, 
several time-saving and skin-care antiseptic 
products are available. In particular alcohol-
based gels or foams added with emollients and 
chlorhexidine may increase the compliance 
to hand hygiene procedures also because 
water rinsing is not needed (52). 
However, it is important to underline 
that the use of these products cannot 
replace the use and the change of gloves 
between a patient and the following one. 
Besides, targeted hand hygiene procedures 
are needed when the presence of a specific 
microorganism requires the use of a particular 
biocide. In these cases, hand-washing with 
soap and water followed by antisepsis is 
recommended (47, 49).
Environmental surfaces disinfection
The role of contaminated health care 
surfaces on the risk of HAIs for patients 
has long been debated but, nowadays, it is 
well-recognized that the environment may 
contribute to the transmission of many health 
care-associated microorganism, such as C. 
difficile, vancomycin-resistant enterococci 
(VRE), MRSA, etc. Indeed, these bacteria 
may pass from contaminated patients and 
staff to environmental surfaces and persists 
on these surfaces for days, increasing the 
causes of hospital mortality, as they cause 
bloodstream infections and their extended-
spectrum production of β-lactamases 
complicates antibiotic therapy (45).
In addition, among the fungi, Aspergillus 
is an important cause of death among 
severely immunosuppressed patients. The 
incidence of nosocomial infections caused 
by Aspergillus has been correlated with 
the contamination of surfaces and air by 
pathogen, suggesting the relevance of the 
environmental control and surveillance 
interventions in high-risk departments, that 
should promptly highlight an inadequate 
functioning of the conditioning systems 
and activate the procedures for adequate 
cleaning and disinfection to prevent fungal 
contamination (46).
Breaking the transmission chain of 
HAIs in hospital environments by 
cleaning and disinfection procedures
Hand hygiene
Healthcare operators’ hands are the 
most relevant vehicle for transmitting 
HAIs (47). Thus, hand hygiene is the 
first and fundamental action to manage 
their occurrence. In this regard, a study 
conducted in England showed that Muslim 
patients wash their hands very frequently 
for religious reasons compared to patients 
belonging to other religions. This difference 
was associated with the lower incidence of 
C. difficile infections that occur in Muslim 
patients (48).
According to WHO (49) and the United 
States Centers for Disease Control and 
Prevention (CDC) (50), hand hygiene 
should be carried out with different methods 
based on the risk associated with the actual 
healthcare procedure: washing with soap and 
water, antiseptic hand washing, antiseptic 
rubbing with alcohol-based (foams or 
gels) hand disinfectants, and surgical hand 
washing.
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possibility of transmission for other patients. 
For these reasons, scientific evidence has 
demonstrated that an appropriate surface 
disinfection is a key procedure for reducing 
HAIs’ incidence (53, 54).
Among the available environmental 
disinfectants, chlorine-based and polyphenols 
products are the most widely used in hospital 
settings (55, 56). On the contrary, alcohol-
based products cannot be used for large 
surfaces due to their short persistence and 
the risk for safety and health consequent to 
vapor generation (57).
As regard to chlorine-based products, 
hypochlorite and sodium dichloro iso-
cyanurate at various concentrations (ranging 
from hundreds to thousands of ppm) 
are used for controlling microbiological 
contamination of corridors, common areas, 
wards, toilets, operating rooms, etc. However, 
the use of chlorine products usually needs 
an accurate preliminary cleaning to reduce 
surfaces’ contamination due to organic 
matter that decreases the concentration of 
the active principle. Recently, some chlorine-
based products containing a surfactant were 
made available (55).
Besides, chlorine derivatives can damage 
different types of materials. The use of 
sodium dichloroisocyanurate solutions may 
overcome most of these problems (58).
Products based on a mixture of two or 
three different phenols added with surfactants 
(the so called “polyphenols”) can be used 
for environmental surfaces’ disinfection 
in the same areas of the hospital settings. 
Main advantages of these products, when 
compared to those chlorine-based, are the 
“one-step”, that is cleaning and disinfecting 
in a single treatment, the higher surficial 
persistence and the absence of damages on 
surfaces. On the other hand, their spectrum 
of action is less wide and they cannot be 
used at high concentrations. In addition, 
polyphenols are recognized as effective 
decontaminants for environmental areas 
contaminated by M. tuberculosis (30).
Other several technologies have proven to 
be effective for disinfecting environmental 
surfaces, such as hydrogen peroxide steam, 
ultraviolet (UV) light and copper and 
silver coated surfaces. Unfortunately, these 
techniques cannot be applied to large surface 
because of technological and practical 
reasons. Some photocatalytic antimicrobial 
coatings are currently recognized as useful 
for their capability to promote the production 
of reactive oxygen species with consequent 
antimicrobial effects under light exposure. 
Several nanotechnological solutions are 
improving this approach by expanding the 
available photocatalytic surface of different 
products mainly based on Titanium Dioxide. 
A promising application of photocatalytic 
materials in hospital settings is aimed to 
prevent HAIs by reducing the microbial 
load in indoor environments. Recent studies 
on antibiotic resistance bacteria showed the 
effectiveness of this strategy in reducing the 
risk of MRSA infection (59).
Disinfection and reprocessing of reusable 
medical devices
According to the recommendation of 
2008 CDC guidelines, the reprocessing of 
reusable medical devices should involve a 
preliminary cleaning. This pre-treatment 
should be performed immediately, just where 
the instrument is used, to avoid the drying 
of biological material that could make the 
reprocessing process fail. This preliminary 
procedure consists of a cleaning with water 
and detergent or water and enzymatic 
detergent (60). The following step consists 
of sterilization, high level or standard 
disinfection, depending on the risk related 
to the specific use of the equipment. Taking 
into account the well-known Spaulding’s 
classification of patient care equipment, 
medical and surgical material can be classified 
as critical, semi-critical and noncritical (61). 
The use of critical devices provides the contact 
with sterile tissues and vascular circulation; 
for this reason, a sterilization treatment is 
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essential for these devices. In particular, if the 
critical instrument is not likely to be damaged 
by heat, steam, pressure or humidity, the 
steam or heat sterilization is considered the 
gold standard procedure. Otherwise, other 
low temperature methods such the use of 
ethylene oxide, plasma gas or peracetic acid 
immersion are recommended (62).
The semi-critical materials come in contact 
with mucous membranes (gastroscopes, 
instruments for respiratory therapies) need 
for a high-level disinfection treatment. 
Even in this case, steam sterilization is the 
gold standard; as many of these items are 
temperature sensitive, high level disinfection 
procedures based on low-temperature 
chemical treatments are necessary (63-
65).
Noncritical materials come in contact 
with intact skin and, consequently, can 
be processed by a disinfectant that has an 
intermediate or low activity level, at the 
recommended concentrations (66-68).
In this context, a particular focus should be 
devoted to endoscopes as their reprocessing 
have many limitations due to their narrow 
lumen and multiple internal channels, as 
well as turning at right angles. In these 
internal surfaces, the bacteria are able to form 
biofilms. A recent multicenter Italian survey, 
involving 22 endoscopy units, reported that 
all studied hospitals performed treatments 
conform to the guidelines; in particular, 55.6% 
of these units used enzymatic detergents (as 
recommended by international guidelines) 
and the most widely used disinfectant was the 
peracetic acid; however, relevant differences 
were found with regard to the periodic quality 
checks (64, 65). This result highlights the 
need for improving the recommendations 
of applying appropriate procedures in the 
reprocessing of these devices.
Bundles
The term “bundle” refers to a series 
of practices that are used collectively 
because together they have much more 
satisfying results than whether they would 
use individually. In particular, a bundle is 
a structured way for improving the care 
processes and the patient outcomes. It 
is based on a structured and small set of 
evidence-based practices (usually three to five 
practices) performed together and constantly, 
in order to ensure the best possible care for 
patients (69). This approach, developed 
in 2001 by the Institute for Healthcare 
Improvement (IHI) in the USA for improving 
patient outcomes, was soon adopted also by 
other countries worldwide. For example, 
the NHS Modernisation Agency’s Critical 
Care Programme in UK take on bundles, 
specifying their characterizing elements 
respect to a checklist or a set of guidelines: 
all changes are necessary and sufficient, all 
changes are based on level 1 evidence, are 
accepted and well established, the changes 
are clear-cut and straightforward involving 
an all-or-nothing approach (70, 71).
Since their introduction, several bundles 
have developed for specific kinds of HAIs 
or high-risk procedures or species of 
microorganisms. As regard to the kind of 
HAIs, a recent systematic review and meta-
analysis on the association of evidence-based 
bundles with surgical site infections (SSIs) 
rates after cesarean delivery demonstrated 
that bundles of three or more evidence-based 
interventions significantly decreased the risk 
of SSIs (72). Besides, several observational 
studies evidenced the importance of the 
bundle approach in the prevention of 
SSIs after other type of interventions. For 
example, Bert et al. demonstrated that the 
application of a 5-items bundle (infection 
risk index calculation, preoperative shower, 
trichotomy, antibiotic prophylaxis, and 
body temperature control) is associated 
to a substantial reduction in SSIs in the 
colon surgery (73). Similarly, another 
observational study evidence that a bundle 
including preoperative chlorhexidine shower, 
a transverse groin incision when clinically 
applicable and a chlorhexidine shower within 
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two postoperative days when the dressings 
were removed determined a significant 
reduction in SSIs after lower extremity 
vascular bypass procedures (74). 
Specific bundles have been developed 
for other high-risk procedures, such as the 
insertion and maintenance care of central 
lines in neonatal, paediatric, and adult ICU 
patients, that are associated with an increase 
of central-line-associated bloodstream 
infections; a systematic review and meta-
analysis on this issue demonstrated a 
potential protective role of central-line 
bundles (insertion or maintenance or both) 
(75). In addition, HAIs associated to urinary 
catheters have been substantially reduced by 
the use of a “bladder” bundle including some 
practices and related measures such as nurse-
initiated urinary catheter discontinuation 
protocol, urinary catheter reminders and 
removal prompts, alternatives to indwelling 
urinary catheterization, portable bladder 
ultrasound monitoring, insertion care and 
maintenance (76).
Regarding specific microorganisms, 
a recent study evidenced the significant 
reduction of paediatric healthcare-associated 
viral infections due to the development of 
targeted prevention practices formalized 
into a comprehensive prevention bundle 
(77). Other specific bundles that can be cited 
are related to C. difficile HAIs, even if until 
under evaluation (78).
Conclusions
This review shows that hand hygiene, 
disinfection procedures and bundles are 
essential strategies for one of the most 
important problem of public health, the HAIs 
occurrence. Indeed, this kind of infections 
are not totally well-controlled, especially 
in hospital environments. It is essential to 
improve the paradigm of the prevention 
strategies with an integrated approach, 
that involves appropriate procedures. 
Considering the most important risk factors 
associated to HAIs, hand hygiene and 
cleaning, disinfection or sterilization of 
surface and instruments are key preventing 
operations. It is important to note that 
the simultaneous application of proper 
procedures/measures/techniques has often 
a stronger effect respect to the application 
of the single intervention. This assumption 
is the rationale of the bundles, a set of 
practices and measures that must be used 
simultaneously. Since the risk of HAIs is 
different according to the procedures and 
the microorganisms of interest, research 
agenda should include the development of 
new bundles, specifically devoted to high-
risk procedures and microorganisms.
Riassunto
Ambiente ospedaliero come reservoir per la trasmis-
sione crociata: procedure di pulizia e disinfezione
Introduzione. Le infezioni correlate all’assistenza 
(ICA) rappresentano un rilevante problema di sanità 
pubblica in quanto aumentano i tassi di morbilità e 
mortalità, presentano un rilevante impatto economico e 
contribuiscono alla resistenza antimicrobica. 
Metodi. Lo scopo della presente revisione è stato 
quello di indagare la letteratura sulle ICA, con particolare 
riferimento agli ambienti ospedalieri e al ruolo delle pro-
cedure di pulizia e disinfezione. L’ambiente ospedaliero 
rappresenta un essenziale reservoir per la trasmissione 
crociata delle ICA e l’applicazione delle procedure relati-
ve al lavaggio delle mani e la disinfezione/sterilizzazione 
di superfici e strumenti rimangono strategie chiave per 
controllare le ICA. 
Risultati. Per l’igiene delle mani si raccomandano 
diversi metodi in funzione del rischio associato alla 
procedura assistenziale: lavaggio con acqua e sapone, 
antisettico e chirurgico, rubbing con disinfettanti a base 
alcolica. Le superfici ambientali possono essere trattate 
con diversi prodotti, maggiormente utilizzati sono di-
sinfettanti a base di cloro e polifenoli. Il reprocessing di 
strumenti è correlato al loro utilizzo secondo la classi-
ficazione di Spaulding. Inoltre, le evidenze scientifiche 
hanno dimostrato l’importanza dei “bundles” (piccoli 
set di pratiche effettuate contemporaneamente) per 
controllare le ICA. 
Conclusioni. Rilevanti research agenda includono 
l’implementazione delle procedure preventive note e lo 
445Cleaning and disinfection in hospital environments
sviluppo di nuovi bundles per procedure ad alto rischio 
e/o specifici microrganismi.
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